Mercurial Pharmaceutical-Biotech Industry Forecasted to Exceed $13 Billion in Capital Project Starts for 2006

---

Reported by Annette Kreuger, Industrialinfo.com (Industrial Information Resources, Incorporated; Houston, Texas). A mounting list of trials and tribulations has not been enough to stem the growing tide of active capital investment by the Pharmaceutical-Biotech Industry. Although regarded by many as the poster child for bad press, the industry currently has nearly 300 North American capital projects scheduled to begin construction this year. Industrialinfo.com’s newly released 2006 Pharmaceutical-Biotech Forecast discusses the many factors that drive and impact industry spending, which is currently pegged at over $13 billion for 2006.

Major projects are no longer the sole province of Big Pharma, as the biotechnology sector remains on a trajectory of growth. With a large amount of drugs awaiting regulatory approval, the sector continues to strengthen its manufacturing capacity to accommodate product launches and for what is hoped, the ensuing demand for the new drugs. Along with manufacturing capacity, research laboratories continue to attract heavy capital investment, as pipelines for both sectors must be continually fed. CMO’s, CRO’s, universities and state and federal agencies all have projects on board.

As in previous editions, Industrialinfo.com’s 2006 Pharmaceutical-Biotech Forecast provides an invaluable resource for providing comprehensive regional, historical, and future spending projections. In addition to offering a clear understanding of the status and direction of the industry, the forecast examines various aspects of drug research, development, and production, including private, government, and academic interests. Emerging trends within the sector are identified and corporate, economic, and regulatory issues are considered. In addition to the updated wall map for 2006, this year’s edition features an increased number of informative top company and product lists.

Unlike any other forecast in the industry, Industrialinfo.com’s online version of the 2006 Pharmaceutical-Biotech Forecast is a "Live" forecast, featuring quarterly updates that offer the latest plant and project spending statistics. When combined with Industrialinfo.com’s Pharmaceutical Tracker - Online Database, the 2006 Pharmaceutical-Biotech Forecast’s analytical plant and project data is backed up by actual plant and project reports.

Industrial Information Resources (IIR) is a Marketing Information Service company that has been doing business for over 22 years. IIR is respected as a leader in providing comprehensive market intelligence pertaining to the industrial processing, heavy manufacturing, and energy-related industries throughout the world.